Anne Tybjærg-Hansen

Anne Tybjærg-Hansen

Clinical Professor


  1. 1998
  2. Published

    Cystic fibrosis Delta F508 heterozygotes, smoking, and reproduction: studies of 9141 individuals from a general population sample

    Dahl, M., Tybjærg-Hansen, Anne, Wittrup, H. H., Lange, Peter & Nordestgaard, Børge, 15 May 1998, In: Genomics. 50, 1, p. 89-96 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma

    Dahl, M., Tybjærg-Hansen, Anne, Lange, Peter & Nordestgaard, Børge, 27 Jun 1998, In: Lancet. 351, 9120, p. 1911-3 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    ΔF508 heterozygosity and asthma (multiple letters) [1]

    Swift, M., Su, Y., Warner, J. O., Lowenfels, A. B., Maisonneuve, P., Palys, B., Schoni, M. H., Redemann, B., Dahl, Morten, Tybjærg-Hansen, Anne, Lange, Peter & Nordestgaard, Børge, 19 Sep 1998, In: Lancet. 352, 9132, p. 984-987 4 p.

    Research output: Contribution to journalLetterResearchpeer-review

  5. 1999
  6. Published

    Baerere af cystisk fibrose har øget risiko for asthma. Osterbroundersøgelsen

    Dahl, M., Tybjærg-Hansen, Anne, Lange, Peter & Nordestgaard, Børge, 9 Aug 1999, In: Ugeskrift for Laeger. 161, 32, p. 4507-9 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. 2001
  8. Published

    Molecular diagnosis of intermediate and severe alpha(1)-antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals

    Dahl, M., Nordestgaard, Børge, Lange, Peter, Vestbo, J. & Tybjærg-Hansen, Anne, Jan 2001, In: Clinical Chemistry. 47, 1, p. 56-62 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Fifteen-year follow-up of pulmonary function in individuals heterozygous for the cystic fibrosis phenylalanine-508 deletion

    Dahl, M., Nordestgaard, Børge, Lange, Peter & Tybjærg-Hansen, Anne, May 2001, In: Journal of Allergy and Clinical Immunology. 107, 5, p. 818-23 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease

    Dahl, M., Tybjærg-Hansen, Anne, Vestbo, J., Lange, Peter & Nordestgaard, Børge, 15 Sep 2001, In: American Journal of Respiratory and Critical Care Medicine. 164, 6, p. 1008-11 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. 2002
  12. Published

    Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population

    Dahl, M., Tybjærg-Hansen, Anne, Lange, Peter, Vestbo, J. & Nordestgaard, Børge, 19 Feb 2002, In: Annals of Internal Medicine. 136, 4, p. 270-9 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. 2003
  14. Published

    Blood pressure, risk of ischemic cerebrovascular and ischemic heart disease, and longevity in alpha(1)-antitrypsin deficiency: the Copenhagen City Heart Study

    Dahl, M., Tybjærg-Hansen, Anne, Sillesen, Henrik, Jensen, G., Steffensen, R. & Nordestgaard, Børge, 11 Feb 2003, In: Circulation. 107, 5, p. 747-52 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Published

    Risk of ischemic heart and ischemic cerebrovascular disease is not increased in S, Z, and 11478A alpha1-antitrypsin carriers of the Copenhagen City Heart Study

    Dahl, M., Tybjærg-Hansen, Anne & Nordestgaard, Børge, 1 Nov 2003, In: Arteriosclerosis, Thrombosis, and Vascular Biology. 23, 11, p. e55; author reply e55

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...34 Next

ID: 924951